Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Data Collection Study on Patients Receiving a DRG Stimulator

Clinical Trial Title: 
A post-approval study to evaluate targeted SCS (DRG) stimulation for the management of moderate to severe chronic, intractable, pain of the lower limbs due to CRPS types I and II.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Timothy R. Lubenow, MD
Clinical Trial Protocol Description: 

Research study to collect data on patients who are receiving a DRG stimulator.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a DRG stimulator implant scheduled.

You will be excluded from the study if any of the following criteria apply to you:

  • Do not have or are not planning on receiving a DRG stimulator.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Pain Management
Contact Phone: 
(312) 942-2985
Contact Name: 
Sherry Robison